RAPT Therapeutics, Inc. Total Assets
RAPT Therapeutics, Inc. had Total Assets of $165.74 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2025-11-06
- 2025-09-30: Assets $165.74M.
- 2025-06-30: Assets $178.41M.
- 2025-03-31: Assets $187.57M.
- 2024-12-31: Assets $240.32M.
| Period end | Assets |
|---|---|
| 2025-09-30 | $165.74M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $178.41M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $187.57M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $240.32M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $108.47M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $127.18M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $155.82M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $173.33M 10-K · filed 2025-03-06 |
| 2023-09-30 | $199.72M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $220.76M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $248.33M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $266.21M 10-K · filed 2024-03-07 |
| 2022-09-30 | $209.49M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $222.00M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $187.55M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $198.64M 10-K · filed 2023-03-14 |
| 2021-09-30 | $217.46M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $231.08M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $105.92M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $118.97M 10-K · filed 2022-03-10 |
| 2020-09-30 | $128.97M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $139.68M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $150.89M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $84.60M 10-K · filed 2021-03-11 |
| 2019-09-30 | $58.37M 10-Q · filed 2019-12-11 |
| 2018-12-31 | $69.61M 10-K · filed 2020-03-30 |